Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production

Multiple Sclerosis Treatments Affect Monocyte-Derived Microvesicle Production

Microvesicles (MVs) are released by immune cells especially of the myeloid lineage upon stimulation with ATP on its cognate receptor P2X7, both in physiological and pathological conditions. In multiple sclerosis (MS) the role of MVs remains little investigated. We aimed to compare the release of MVs...

Full description

Bibliographic Details
Main Authors: Maria Blonda, Antonella Amoruso, Roberta Grasso, Valeria Di Francescantonio, Carlo Avolio
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
microvesicles
monocytes
disease modifying drugs
Inferferon beta
Teriflunomide
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2017.00422/full

Internet

http://journal.frontiersin.org/article/10.3389/fneur.2017.00422/full

Similar Items